Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome-Negative Lymphoblastic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07105579
What this trial is testing

Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaRelapse
First Affiliated Hospital of Zhejiang University 31
Not applicableStudy completedNCT03647215
What this trial is testing

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Who this might be right for
Chronic Phase Chronic Myelogenous LeukemiaAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous Leukemia+1 more
Incyte Biosciences UK 427
Testing effectiveness (Phase 2)Study completedNCT01769209
What this trial is testing

Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Adult Acute Lymphoblastic Leukemia (ALL)Ph-positive Adult Acute Lymphoblastic Leukemia (ALL)Recurrent Adult Acute Lymphoblastic Leukemia (ALL)+1 more
Stanford University 18
Testing effectiveness (Phase 2)Study completedNCT05594784
What this trial is testing

Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALL

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 79
Not applicableLooking for participantsNCT07454226
What this trial is testing

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

Who this might be right for
Ph-LikeAcute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 92
Not applicableUnknownNCT02617004
What this trial is testing

Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults

Who this might be right for
Philadelphia Chromosome Negative Adult B-cell Acute Lymphoblastic Leukemia
Assistance Publique - Hôpitaux de Paris 500
Post-approval studies (Phase 4)UnknownNCT01990807
What this trial is testing

Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

Who this might be right for
Childhood Acute Lymphoblastic LeukemiaPhiladelphia Chromosome, Ph^1^, AbsentB-cell Childhood Acute Lymphoblastic Leukemia
Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)Ended earlyNCT01028716
What this trial is testing

Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Biphenotypic LeukemiaAcute Erythroid Leukemia in RemissionAcute Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 46
Testing effectiveness (Phase 2)Ended earlyNCT02629692
What this trial is testing

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Who this might be right for
Healthy (For Part A)Chronic Myeloid Leukemia (for Part B and C)
Sun Pharma Advanced Research Company Limited 124
Testing effectiveness (Phase 2)UnknownNCT00008307
What this trial is testing

Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Herbert Irving Comprehensive Cancer Center 52
Testing effectiveness (Phase 2)Looking for participantsNCT03739814
What this trial is testing

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Temporarily pausedNCT01222013
What this trial is testing

Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)
Renato Melaragno 20
Not applicableUnknownNCT03318770
What this trial is testing

Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 60
Testing effectiveness (Phase 2)Study completedNCT01256398
What this trial is testing

Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
National Cancer Institute (NCI) 66
Not applicableUnknownNCT05024357
What this trial is testing

TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-LymphomaPhiladelphia-Positive Acute Lymphoblastic LeukemiaALL, Adult
First Affiliated Hospital Xi'an Jiaotong University 80
Not applicableStudy completedNCT03118128
What this trial is testing

Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Hospital General de Mexico 102
Testing effectiveness (Phase 2)Study completedNCT00337454
What this trial is testing

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

Who this might be right for
Chronic Myelogenous Leukemia
Bristol-Myers Squibb 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178912
What this trial is testing

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Phase II Clinical TrialBlinatumomabOlverembatinib+2 more
M.D. Anderson Cancer Center 60